DeborahMichelleGurnerMD

Internal Medicine • Brooklyn, NY

Physician

Join to view full profile

Dr. Gurner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gurner's full profile

Already have an account?

Office
295 Saint Johns Pl
No. 3b
Brooklyn, NY 11238
Phone+1 917-628-1405

Education & Training

New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1996 - 1997
Columbia University Vagelos College of Physicians and SurgeonsClass of 1996

Certifications & Licensure

NY State Medical License 1997 - 2026

Publications & Presentations

PubMed

2 citations
Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis.
Kenneth G. Saag, Tobias J. de Villiers, Peter Alexandersen, Heidi Jacobe, Carrie L. Kovarik
Journal of the American Academy of Dermatology. 2021-04-01
18 citations
Incidence of hypersensitivity and anaphylaxis with sugammadex.
K. Chris Min, Tiffany Woo, Christopher Assaid, Jacqueline B. McCrea, Deborah M. Gurner
Journal of Clinical Anesthesia. 2018-06-01
38 citations
Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled T...
Sydney Lou Bonnick, Tobias De Villiers, Alberto Odio, Santiago Palacios, Roland Chapurlat
The Journal of Clinical Endocrinology and Metabolism. 2013-09-24

Authored Content

Incidence of Hypersensitivity and Anaphylaxis with SugammadexApril 2018